Literature DB >> 15284234

Dissecting the protein-protein interface between beta-lactamase inhibitory protein and class A beta-lactamases.

Zhen Zhang1, Timothy Palzkill.   

Abstract

beta-Lactamase inhibitory protein (BLIP) binds and inhibits a diverse collection of class A beta-lactamases at a wide range of affinities. Alanine-scanning mutagenesis was previously performed to identify the amino acid sequence requirements of BLIP for inhibiting TEM-1 beta-lactamase and SME-1 beta-lactamase. Two hotspots of binding energy, one from each domain of BLIP, were identified (Zhang, Z., and Palzkill, T. (2003) J. Biol. Chem. 278, 45706-45712). This study has been extended to examine the amino acid sequence requirements of BLIP for binding to the SHV-1 beta-lactamase, which is a poor binding substrate (Ki= 1.1 microm), and the Bacillus anthracis Bla1 enzyme (Ki= 2.5 nm). The two hotspots previously identified as important for binding TEM-1 and SME-1 beta-lactamase were also found to be important for binding Bla1. The hotspot from the second domain of BLIP, however, does not make substantial contributions to SHV-1 binding. This may explain why BLIP binds to SHV-1 beta-lactamase with much weaker affinity than to the other three enzymes. Three regions, including two loops that insert into the active pocket of TEM-1 beta-lactamase and the Glu-73-Lys-74 buried charge motif, exhibit strikingly different effects on the binding affinity of BLIP toward the various enzymes when mutated and, therefore, act as specificity determinants. Analysis of double mutants of BLIP that combine specificity-determining residues suggests that these residues contribute to the poor affinity between the second domain of BLIP and SHV-1 beta-lactamase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284234     DOI: 10.1074/jbc.M406157200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display.

Authors:  N G Brown; T Palzkill
Journal:  Protein Eng Des Sel       Date:  2010-03-22       Impact factor: 1.650

Review 2.  Protein binding specificity versus promiscuity.

Authors:  Gideon Schreiber; Amy E Keating
Journal:  Curr Opin Struct Biol       Date:  2010-11-09       Impact factor: 6.809

3.  Directed mutagenesis identifies amino acid residues involved in elongation factor Tu binding to yeast Phe-tRNAPhe.

Authors:  Lee E Sanderson; Olke C Uhlenbeck
Journal:  J Mol Biol       Date:  2007-02-06       Impact factor: 5.469

4.  Computational redesign of the SHV-1 beta-lactamase/beta-lactamase inhibitor protein interface.

Authors:  Kimberly A Reynolds; Melinda S Hanes; Jodi M Thomson; Andrew J Antczak; James M Berger; Robert A Bonomo; Jack F Kirsch; Tracy M Handel
Journal:  J Mol Biol       Date:  2008-05-29       Impact factor: 5.469

5.  Analysis of the binding forces driving the tight interactions between beta-lactamase inhibitory protein-II (BLIP-II) and class A beta-lactamases.

Authors:  Nicholas G Brown; Dar-Chone Chow; Banumathi Sankaran; Peter Zwart; B V Venkataram Prasad; Timothy Palzkill
Journal:  J Biol Chem       Date:  2011-07-20       Impact factor: 5.157

6.  Use of periplasmic target protein capture for phage display engineering of tight-binding protein-protein interactions.

Authors:  Bartlomiej G Fryszczyn; Nicholas G Brown; Wanzhi Huang; Miriam A Balderas; Timothy Palzkill
Journal:  Protein Eng Des Sel       Date:  2011-09-06       Impact factor: 1.650

7.  BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A β-Lactamases.

Authors:  Carolyn J Adamski; Timothy Palzkill
Journal:  Biochemistry       Date:  2017-02-16       Impact factor: 3.162

8.  BLIP-II is a highly potent inhibitor of Klebsiella pneumoniae carbapenemase (KPC-2).

Authors:  Nicholas G Brown; Dar-Chone Chow; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

9.  Engineering Specificity from Broad to Narrow: Design of a β-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC β-Lactamase.

Authors:  Dar-Chone Chow; Kacie Rice; Wanzhi Huang; Robert L Atmar; Timothy Palzkill
Journal:  ACS Infect Dis       Date:  2016-10-26       Impact factor: 5.084

10.  A tool for calculating binding-site residues on proteins from PDB structures.

Authors:  Jing Hu; Changhui Yan
Journal:  BMC Struct Biol       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.